UNITED STATES SURGICAL CORP
S-8, 1994-05-26
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: UNION CARBIDE CORP /NEW/, POS AM, 1994-05-26
Next: UNITED STATES SURGICAL CORP, S-8, 1994-05-26



<PAGE>   1
                                                           REGISTRATION NO. 33-


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

                             REGISTRATION STATEMENT

                                     UNDER

                           THE SECURITIES ACT OF 1933

                       UNITED STATES SURGICAL CORPORATION
             (Exact name of registrant as specified in its charter)

DELAWARE                                                     13-2518270
(State or other jurisdiction                                 (I.R.S. Employer
of organization or incorporation)                            Identification No.)
                                                                
150 GLOVER AVENUE, NORWALK, CONNECTICUT                      06856
(Address of principal executive offices)                     (Zip Code)
                                                                


                        1993 EMPLOYEE STOCK OPTION PLAN
                            (FULL TITLE OF THE PLAN)

                              Donald F. Crane, Jr.
                               Senior SEC Counsel
                       United States Surgical Corporation
                               150 Glover Avenue
                           Norwalk, Connecticut 06856
                    (Name and address of agent for service)

                                 (203) 845-1000
         (Telephone number, including area code, of agent for service)

                        CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
- ----------------------------------------------------------------------------------------
                                             PROPOSED       PROPOSED                    
                                             MAXIMUM        MAXIMUM                     
  TITLE OF              AMOUNT               OFFERING       AGGREGATE       AMOUNT OF   
  SECURITIES TO BE      TO BE                PRICE          OFFERING        REGISTRATION
  REGISTERED            REGISTERED           PER SHARE*     PRICE*          FEE         
- ----------------------------------------------------------------------------------------
  <S>                   <C>                  <C>            <C>                 <C>      
  COMMON STOCK,                                                                         
  PAR VALUE                                                                             
  $.10 PER SHARE        1,500,000 SHARES     $17.75         $26,625,000         $9,181.03       
- ----------------------------------------------------------------------------------------
</TABLE>

*Estimated pursuant to Rule 457 only for purposes of calculating the
registration fee, based upon the average of the high and low price per share on
May 23, 1994, as reported in the composite reporting system for New York Stock
Exchange listed issues.
<PAGE>   2
       This registration statement relates to the registration of additional
securities of the same class for which a registration statement filed on Form
S-8 relating to the 1993 Employee Stock Option Plan is effective.  The contents
of the earlier registration statement (Registration No.  33-59278; commission
file number 1-9776) are incorporated by reference in this registration
statement.


ITEM 8.  EXHIBITS.


     (5)       Opinion of Donald F. Crane, Jr.*

     (15)      Letter re unaudited interim financial information.*

     (23)(a)   Consent of Deloitte & Touche.*

       (b)     Consent of Donald F. Crane, Jr. (included in Exhibit 5).

     (24)      Powers of Attorney.*

     *Filed herewith
<PAGE>   3
                                   SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Norwalk, State of Connecticut, on May 25, 1994.

                                   UNITED STATES SURGICAL CORPORATION
                                    
                                   By /s/ Thomas R. Bremer
                                      ----------------------------------------
                                       Thomas R. Bremer
                                       Senior Vice President and General Counsel


         PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, THIS
REGISTRATION STATEMENT HAS BEEN SIGNED BY THE FOLLOWING PERSONS IN THE
CAPACITIES AND ON THE DATES INDICATED.

<TABLE>
<CAPTION>
              Signature                                 Title                                   Date
              ---------                                 -----                                   ----
<S>                                        <C>                                              <C>
                 *                         Chairman of the Board, President,                May 25, 1994
- -------------------------------------      Chief Executive Officer and Director                         
         Leon C. Hirsch                    (Principal Executive Officer)               
                                                                                       
                                                   
                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         John A. Bogardus, Jr.

     /s/ Thomas R. Bremer                  Director                                         May 25, 1994
- --------------------------------------                                                                  
         Thomas R. Bremer

                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         Turi Josefsen

                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         Douglas L. King

                                           Director                                         
- -------------------------------------                                                                   
         Zanvyl Krieger

                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         Bruce S. Lustman

                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         William F. May

                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         Marianne Scipione

                 *                         Director                                         May 25, 1994
- -------------------------------------                                                                   
         Douglas T. Tansill

                 *                         Senior Vice President, Finance                   May 25, 1994
- -------------------------------------      and Chief Financial Officer                                  
         Howard M. Rosenkrantz             (Principal Financial Officer)
                                                                                
                                           
                 *                         Vice President and Controller                    May 25, 1994
- -------------------------------------      (Principal Accounting Officer)                               
         Joseph C. Scherpf                                                       
</TABLE>                                           


* By power of Attorney
<PAGE>   4
                                 EXHIBIT INDEX



Exhibit No.                     Item                              Location
- ------------                    ----                              --------

   5                 Opinion of Donald F. Crane, Jr.

   15                Letter re unaudited interim financial
                          information

   23(a)             Consent of Deloitte & Touche

   24                Power of Attorney

<PAGE>   1





                                 EXHIBIT NO. 5
<PAGE>   2





                                     May 25, 1994

  

United States Surgical Corporation
150 Glover Avenue
Norwalk, Connecticut  06856

Dear Sirs:

     I refer to the Registration Statement on Form S-8 (the "Registration
Statement") to be filed by United States Surgical Corporation, a Delaware
corporation (the "Company"), on or about the date hereof with the Securities
and Exchange Commission in connection with the registration under the
Securities Act of 1933, as amended, of an aggregate of 1,500,000 shares of the
Company's common stock, par value $.10 per share (the "Common Stock"), for
issuance on the exercise of stock options granted pursuant to the Company's
1993 Employee Stock Option Plan (the "Plan").

     I am familiar with the Certificate of Incorporation and By-laws of the
Company and have examined copies of the Plan, the resolutions adopted by the
Company's Board of Directors with respect to the Plan and originals or copies,
certified or otherwise identified to my satisfaction, of such other
instruments, and have made such other investigations of law and fact, as I have
deemed necessary or appropriate for the purposes of this opinion.

     Based upon the foregoing, it is my opinion that the 1,500,000 shares of
Common Stock authorized for issuance pursuant to the Plan have been duly
authorized and, when issued in accordance with the Plan and upon payment of the
purchase price therefor, will be validly issued, fully paid and nonassessable.

     I hereby consent to the use of this opinion in the Registration Statement.

                                     Very truly yours,


                                     Donald F. Crane, Jr.
                                     Senior SEC Counsel

<PAGE>   1





                                 EXHIBIT NO. 15
<PAGE>   2




May 24, 1994



United States Surgical Corporation
150 Glover Avenue
Norwalk, CT  06856

We have made a review, in accordance with standards established by the American
Institute of Certified Public Accountants, of the unaudited interim financial
information of United States Surgical Corporation and subsidiaries for the
three-month periods ended March 31, 1994 and 1993 as indicated in our report
dated April 22, 1994; because we did not perform an audit, we expressed on
opinion on that information.

We are aware that our report referred to above, which was included in your
Quarterly Report on Form 10-Q for the quarter ended March 31, 1994 is being
incorporated by reference in this Registration Statement on Form S-8.

We also are aware that the aforementioned report, pursuant to Rule 436(c) under
the Securities Act of 1933, is not considered a part of the Registration
Statement prepared or certified by an accountant or a report prepared or
certified by an accountant within the meaning of Sections 7 and 11 of that Act.



/s/ Deloitte & Touche

New York, New York

<PAGE>   1





                               EXHIBIT NO. 23(a)
<PAGE>   2





INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this Registration Statement of
United States Surgical Corporation on Form S-8 of our report dated February 1,
1994 except as to Notes H, K and L, as to which the date is March 28, 1994,
appearing in the Annual Report on Form 10-K of United States Surgical
Corporation for the year ended December 31, 1993.


/s/ Deloitte & Touche

New York, New York
May 24, 1994

<PAGE>   1





                                 EXHIBIT NO. 24
<PAGE>   2
                               POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned officers and
directors of UNITED STATES SURGICAL CORPORATION, a Delaware corporation (the
"Company"), in connection with the filing with the Securities and Exchange
Commission, Washington, D.C., under the provisions of the Securities Act of
1933, as amended, (the "Act") of a Registration Statement on Form S-8 with 
respect to the registration under the Act of 1,500,000 shares of the Company's 
common stock, par value $.10 per share, issuable on exercise of stock options 
which may be awarded pursuant to the Company's 1993 Employee Stock Option Plan,
hereby constitutes and appoints Thomas R. Bremer and Howard M. Rosenkrantz such
undersigned's true and lawful attorneys-in-fact and agents, and each of them
with full power to act without the other as such undersigned's true and lawful
attorney-in-fact and agent, for and in the name, place and stead of such
undersigned, in any and all capacities, to sign said Registration Statement and
any and all future amendments thereto and to file said Registration Statement
and each such future amendment, with all exhibits thereto, and any and all
other documents in connection therewith, with the Securities and Exchange
Commission, hereby granting unto said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform any and all acts and things
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as such undersigned might or could do in person, hereby
ratifying and confirming all the said attorneys-in-fact and agents, or either
or them, may lawfully do or cause to be done by virtue hereof.
<PAGE>   3

     IN WITNESS WHEREOF, the undersigned have hereunto set their hands and
seals this 18th day of May, 1994.



<TABLE>
<S>                                                       <C>
/s/ Leon C. Hirsch                                        /s/ Douglas L. King
- -------------------------------------                     ---------------------------------
Leon C. Hirsch                                            Douglas L. King
Chairman of the Board, President,                         Director
Chief Executive Officer and Director
(Principal Executive Officer)


/s/ John A. Bogardus                                      /s/ William F. May
- -------------------------------------                     ---------------------------------
John A. Bogardus                                          William F. May
Director                                                  Director


/s/ Thomas R. Bremer                                      /s/ Marianne Scipione
- -------------------------------------                     ---------------------------------
Thomas R. Bremer                                          Marianne Scipione
Director                                                  Director


/s/ Howard M. Rosenkrantz                                 /s/ Douglas T. Tansill
- -------------------------------------                     ---------------------------------
Howard M. Rosenkrantz                                     Douglas T. Tansill
Senior Vice President, Finance,                           Director
Chief Financial Officer
(Principal Financial Officer)


/s/ Turi Josefsen                                         /s/ Joseph C. Scherpf    
- -------------------------------------                     ---------------------------------
Turi Josefsen                                             Joseph C. Scherpf
Director                                                  Vice President and Controller
                                                          (Principal Accounting Officer)

/s/ Bruce S. Lustman                                      
- -------------------------------------                     
Bruce S. Lustman                                          
Director                                                  
                                                          
</TABLE>





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission